Christopher Martin
Voorzitter bij Tokamak Energy Ltd.
Vermogen: 7 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Christopher Martin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 | |
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom.
8
| Subsidiary | Medical/Nursing Services | 8 |
| Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 8 | |
Osivax SAS
 Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.
8
| Holding Company | Biotechnology | 8 |
Tagworks Pharmaceuticals BV
 Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011.
7
| Holding Company | Biotechnology | 7 |
Myricx Pharma Ltd.
 Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Tokamak Energy Ltd.
 Tokamak Energy Ltd. BiotechnologyHealth Technology Tokamak Energy Ltd. provides medical and biotechnology services. It develops the potential to use fusion neutrons for a variety of applications from material treatments to medical applications or low cost hydrogen production. The company was founded by David Richard Kingham, Mikhail Gryaznevich and Alan Sykes in 2009 and is headquartered in Abingdon, the United Kingdom.
6
| Holding Company | Biotechnology | 6 |
Xenva Ltd.
 Xenva Ltd. Miscellaneous Commercial ServicesCommercial Services Xenva Ltd. provides boutique management services. The company was founded on June 19, 1997 and is headquartered in Hampshire, the United Kingdom.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Cascade Fund Management Ltd.
2
| Subsidiary | 2 | |
Spirogen SARL
 Spirogen SARL Pharmaceuticals: MajorHealth Technology Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christopher Martin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Chief Operating Officer Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
BRIT Insurance Holdings Ltd.
 BRIT Insurance Holdings Ltd. Multi-Line InsuranceFinance BRIT Insurance Holdings Ltd. provides commercial insurance products. The company was founded by Neil David Eckert on October 30, 1995 and is headquartered in London, the United Kingdom. | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Association of Investment Cos.
 The Association of Investment Cos. Investment Trusts/Mutual FundsMiscellaneous The Association of Investment Cos. is based in London, UK. The British company represents and provides investor data on closed-ended funds, including investment trusts and venture capital trusts (VCTs). The non-profit company was founded in 1932. Richard William Stone has been the CEO of the company since 2021. | Investment Trusts/Mutual Funds | Chairman Chairman | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| THE BIOTECH GROWTH TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree | |
KuDOS Pharmaceuticals Ltd.
 KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Doctorate Degree | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| The University of Nottingham | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Private Equity Analyst Director/Board Member | |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder Private Equity Investor | |
Auven Therapeutics Holdings LP
 Auven Therapeutics Holdings LP Investment ManagersFinance Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments. | Investment Managers | Founder Chief Executive Officer | |
| BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member Chairman | |
InSphero AG
 InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
Badertscher Rechtsanwälte AG
 Badertscher Rechtsanwälte AG Miscellaneous Commercial ServicesCommercial Services Badertscher Rechtsanwälte AG is a national and internationally recognized law firm specializing in business, tax, and notary law, with offices in Zurich and Zug, Switzerland. The firm provides legal services to Swiss and foreign companies, public institutions, and individuals. The team of two dozen lawyers offers comprehensive legal advice in private and public law. The firm's approach is holistic, efficient, and solution-oriented, with a focus on tailored solutions that meet clients' needs. The firm's areas of expertise include insurance and liability law, corporate law, and public law. The firm also offers career opportunities for lawyers interested in joining their team. | Miscellaneous Commercial Services | Corporate Officer/Principal President | |
Pradeyrol Développement
 Pradeyrol Développement Financial ConglomeratesFinance Pradeyrol Développement SC operates as an investment holding company. It invests in the biotechnology sector and mainly on molecular diagnostics. The company was founded on August 16, 2007 and is headquartered in Paris, France. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Stade Français Paris SA
 Stade Français Paris SA Movies/EntertainmentConsumer Services Stade Français Paris SA owns and operates rugby union club. It offers rugby training for professionals, non-professionals, and children. The company was founded in in May 1995 and is headquartered in Paris, France. | Movies/Entertainment | Chairman Director/Board Member | |
Transcriptogen Ltd.
 Transcriptogen Ltd. BiotechnologyHealth Technology Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
ADC Therapeutics (UK) Ltd.
 ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The company is based in Reading, UK and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
VaxEquity Ltd.
 VaxEquity Ltd. BiotechnologyHealth Technology VaxEquity Ltd. is a UK biotechnology company founded in 2020 by Professor Robin Shattock, the head of immunology of infection at Imperial College and Morningside. The company is based in Little Chesterford, UK. The British company is developing transformative RNA therapeutics and vaccines using its next-generation self-amplifying RNA platform called SARNA. The platform provides extended duration of protein expression, enabling lower doses to be used for vaccines and higher protein levels to be achieved for therapeutics. VaxEquity is pioneering a next-generation approach by modifying its SARNA to modulate the innate immune response and thereby overcoming current limitations. The flexibility of the company's platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale. | Biotechnology | Director/Board Member Chairman | |
Pheon Therapeutics Ltd.
 Pheon Therapeutics Ltd. BiotechnologyHealth Technology Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023. | Biotechnology | Chief Executive Officer Founder | |
| WORLDWIDE HEALTHCARE TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 19 |
| Verenigde Staten | 15 |
| Frankrijk | 6 |
| Zwitserland | 5 |
| Noorwegen | 3 |
Sectoraal
| Health Technology | 28 |
| Finance | 8 |
| Consumer Services | 8 |
| Miscellaneous | 5 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 326 |
| Corporate Officer/Principal | 123 |
| Chairman | 96 |
| Independent Dir/Board Member | 84 |
| Chief Executive Officer | 40 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas M. Rinderknecht | 34 |
| Stephen Evans-Freke | 34 |
| Susan Foden | 32 |
| Maina Bhaman | 26 |
| Jean Bizzari | 24 |
| Jacques Theurillat | 22 |
| Viviane Monges | 22 |
| David Warren East | 21 |
| Robert Charles Hubert Jeens | 20 |
| J. Anthony Townsend | 19 |
| Stephen Thompson | 18 |
| Michael Forer | 18 |
| John Barrie Ward | 18 |
| Tyrell J. Rivers | 17 |
| Robert Azelby | 15 |
- Beurs
- Insiders
- Christopher Martin
- Bedrijfsconnecties
